AXL and cancer: AXL is a well-established negative-feedback regulator of the innate immune response by dampening the TLR response[173], and as AXL inhibition has been shown to elicit an immunogenic form of cell death in cancer cells, it is expected to initiate a strong innate anticancer immune response through recruitment and activation of APCs[53,124,170].